Company: MDCXW
Filing Date: 2025-08-22
Form Type: 253G2
Source: 0001062993-25-014831
Chunk: 4

Company: Medicus Pharma Ltd.
Filing Date: 2025-08-22
Form: 253G2
Chunk 4
---
AR and on SEDAR+, which may impact, among other things, the trading price and liquidity of the Company's common shares. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof and thus are subject to change thereafter. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Readers are cautioned that the foregoing list is not exhaustive, and readers are encouraged to review the Company's long form prospectus accessible on the Company's profile on EDGAR at www.sec.gov and on SEDAR+ at www.sedarplus.ca. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

| MEDICUS PHARMA LTD. |     |                                                |
| By:                 |     | /s/ Raza Bokhari                               |
| Name:               |     | Dr. Raza Bokhari                               |
| Title:              |     | Executive Chairman and Chief Executive Officer |

Dated: August 22, 2025